You are here
Edited by the College's Washington, DC Governmental Affairs Division, the ACP Advocate is a bi-weekly, e-newsletter created to provide ACP members with news about public policy issues affecting internal medicine and patient care.
CMS releases mostly positive Medicare Physician Fee Schedule proposal; CMS rule allows for physician flexibility in MACRA implementation; ACP doctor advocates for pharmaceutical reform with Congressman.
ACP urges congressional action on Zika virus, opioid addiction, health research and primary care amid budget debate; Life and death of Aetna Innovation Labs director highlights need for patient-centered care
An important CPC+ update includes a Sept. 15 participation deadline; ACP-priority legislation recently was passed by Congress and signed by the president. Marking a huge "win" for ACP, it cracks down on opioid abuse.
ACP urges CMS to make some adjustments to its plans for MACRA; Dr. Nitin Damle testifies on drug pricing at Capitol Hill hearing; ACP escalates its efforts to recognize gun violence as a serious threat to public health.
ACP takes stock of the issues that still need to receive attention from Congress this year; CMS agrees to suggestions from physicians on benchmarks for practices in the ACO model; How Dr. Tammy Lin was able to use her experience at Leadership Day to engage in further advocacy.
ACP tells Congress to take the necessary measures to contain the threat of Zika virus; The new Legislative Action Center enhances advocacy abilities for members to better reach Congressional leaders; Coverage of this year's Richard Neubauer Advocate for Internal Medicine Award, Dr. Alejandro Moreno.
ACP offers advice and resources on how physicians can prepare for MACRA; Another successful Leadership Day event allowed members to engage with staffers on Capitol Hill; The FDA has put on new regulations on tobacco, earning praise from ACP.
CMS releases details on the Comprehensive Primary Care Plus program; Dr. Robert McLean testifies in front of the House Energy & Commerce Subcommittee on Health regarding MACRA; ACP and AAIM jointly release a paper focused on changes to the financing of graduate medical education.
ACP releases position paper on Climate Change; Giving input to Congress on appropriations for several important health care programs; Survey findings show what has changed in the medical profession and how physicians are responding.
ACP releases position paper on prescription drug costs; CDC's offers new guideline on prescribing opioid painkillers; ACP joins 22 other organizations in calling on CMS to do more to provide appropriate benchmarks for ACOs.
ACP releases position paper on options for Medicaid expansion; Some potential legislative movement on telemedicine may come this year; Kaiser Family Foundation releases a report evaluating various Medicare payment models.
ACP sends comments to CMS on quality measure development; ACP acts as part of a coalition on the process of aligning performance measures with practice; Leadership Day, ACP's annual event allowing members to engage in legislative advocacy, is quickly approaching
ACP works with congress on interoperability for a new law on health IT to be considered in April; Recommendations are submitted on updates to the Stark self-referral law; A new report on patient-centered medical homes finds reductions in cost and unnecessary utilization.
ACP's web page on the major health care issues to consider during the 2016 presidential election; ACP sends a letter to the Senate Finance Committee on ways to improve chronic care; Feedback provided to CMS on changes that need to be made to eMeasures.
ACP submits comments to the CDC on their draft guidelines for prescription of opioids for chronic pain; How the President's executive actions on firearms stack up with ACP policy; Several health care issues make it into the president's State of the Union address.
What physicians need to know about regulations and deadlines in 2016; A review of some of ACP's biggest legislative wins from 2015; Federal spending levels bring some change for health care, especially in research.